Product Information
CARBINOXAMINE 4 MG/5 ML LIQUID is a generic product labeled by Genus Lifesciences Inc., priced at $0.9565 per ML under NDC 64950024304. Its NADAC has been published 82 times since Nov 20, 2024.
FDA first approved this application on Apr 25, 2003.
Strength
4 mg/5mL
Manufacturer
Genus Lifesciences Inc.NDC
64950024304
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
CARBINOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA040458FDA Approved
4/25/2003
On Market Since
6/9/2023
Pharmacological Classes
Price Statistics
The NADAC for CARBINOXAMINE 4 MG/5 ML LIQUID has been published 82 times since Nov 20, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9565 per ML |
|---|---|
| All-time high | $0.9576 (Feb 12, 2025) |
| All-time low | $0.9292 (Mar 19, 2025) |
| 52-week high | $0.9565 |
| 52-week low | $0.9565 |
| Median price | $0.9565 |
| Average price | $0.9528 |
| Largest weekly change | -1.5% (Mar 19, 2025) |
| Weeks tracked | 82 |
| Tracking since | Nov 20, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-0.1%
Last surveyed Jun 10, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Carbinoxamine Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genus Lifesciences Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carbinoxamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARBINOXAMINE 4 MG/5 ML LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for CARBINOXAMINE 4 MG/5 ML LIQUID, manufactured by Genus Lifesciences Inc., is $0.9565 per ML (NDC 64950024304), effective Jun 10, 2026.
How has the price of CARBINOXAMINE 4 MG/5 ML LIQUID changed over time?
Over the history we have for it, the NADAC for CARBINOXAMINE 4 MG/5 ML LIQUID has held within roughly two percent of its current level. It has been tracked across 82 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CARBINOXAMINE 4 MG/5 ML LIQUID?
Since Nov 20, 2024, the NADAC for CARBINOXAMINE 4 MG/5 ML LIQUID has ranged from a low of $0.9292 (Mar 19, 2025) to a high of $0.9576 (Feb 12, 2025), with a median of $0.9565 per ML.
Are there cheaper alternatives to CARBINOXAMINE 4 MG/5 ML LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of CARBINOXAMINE 4 MG/5 ML LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CARBINOXAMINE 4 MG/5 ML LIQUID?
CARBINOXAMINE 4 MG/5 ML LIQUID (NDC 64950024304) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.